Archive: 18/04/2023
Glaxo buys Canadian cough drug maker for $2 bn
British drugmaker GlaxoSmithKline on Tuesday announced the purchase of Canadian chronic cough treatment specialist Bellus for US$2 billion.
Apr 18, 2023
British drugmaker GlaxoSmithKline on Tuesday announced the purchase of Canadian chronic cough treatment specialist Bellus for US$2 billion.
Apr 18, 2023